Phase II trial of paclitaxel by three-hour infusion for advanced gastric cancer with short premedication for prophylaxis against paclitaxel-associated hypersensitivity reactions
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/12/8/1133/19479736/12-8-1133.pdf
Reference24 articles.
1. The movement of population;Health and welfare statistics association;J Health and Welfare Statistics,1999
2. Phase III study of UFT+ MMC vs. 5-FU+ CDDP vs. 5-FU alone in patients with advanced gastric cancer: JCOG Study 9205;Shimada;Proc Am Soc Clin Oncol,1999
3. Final Results of a Randomized Phase III Trial of Sequential High-Dose Methotrexate, Fluorouracil, and Doxorubicin Versus Etoposide, Leucovorin, and Fluorouracil Versus Infusional Fluorouracil and Cisplatin in Advanced Gastric Cancer: A Trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group
4. Phase II study of a combination of irinotecan and cisplatin against metastatic gastric cancer;Boku;J Clin Oncol,1999
5. Plant antitumor agents. VI The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia;Wani;J Am Chem Soc,1971
Cited by 117 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Optimizing the Continuum of Care in Gastric Cancer;OncoTargets and Therapy;2023-11
2. Microtubule Inhibitors;Holland‐Frei Cancer Medicine;2023-02-20
3. Review Article: Mechanisms and Efficacy of Using Diphenhydramine as a Chemotherapy Premedication;Journal of Pharmaceutical Negative Results;2022-10-13
4. Efficacy and safety of combination chemotherapy regimens containing taxanes for first-line treatment in advanced gastric cancer;Clinical and Experimental Medicine;2022-04-16
5. Pre-medication protocols for the prevention of paclitaxel-induced infusion related reactions: a systematic review and meta-analysis;Supportive Care in Cancer;2022-02-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3